Results 121 to 130 of about 20,955 (188)

Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial. [PDF]

JAMA Netw Open
Xia C, Smith AM, Lefebvre B, Jamal FA, Armenian SH, Koropeckyj-Cox D, Zhang L, Liu PP, Landsburg D, Clark AS, Shah PD, Hubbard RA, Huang A, Golec S, Hewitt M, Wilcox NS, Chen Z, Rethy L, Jung W, Ko K, Narayan V, Martei YM, Lang NN, Januzzi JL, Felker GM, Ky B.   +25 more
europepmc   +1 more source

Cardioprotection Reloaded: Reflections on 40 Years of Research. [PDF]

Antioxidants (Basel)
Pagliaro P, Alloatti G, Penna C.
europepmc   +1 more source

Cardioprotective Effect of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Is Mediated by Sarcolemmal but Not Mitochondrial ATP-Sensitive Potassium Channels in Rats with Systemic Inflammation. [PDF]

Int J Mol Sci
Borshchev YY, Burovenko IY, Karaseva AB, Minasian SM, Gordeev AD, Borshchev VY, Butko DY, Borshcheva OV, Suvorov AN, Galagudza MM.   +9 more
europepmc   +1 more source

Cardioprotective Agent [PDF]

, 2020
openaire   +1 more source

Molecular and Cellular Mechanisms of Cardioplegic Protection in Surgical Myocardial Revascularization. [PDF]

Cells
Lazović DM, Karadžić Kočica M, Ivanišević D, Aleksić V, Kočica MJ, Grujić D, Mihajlović JM, Cvetković D, Juričić SA.   +8 more
europepmc   +1 more source

Evaluating Semaglutide's Protection in H/R - Injured AC16 Cardiomyocytes: Oxidative Stress, Inflammation, Apoptosis, and Autophagy Insights. [PDF]

Int J Gen Med
Li L, Jin L, Wang J.
europepmc   +1 more source

Targeting of Cdc42-Interacting Protein 4-Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction. [PDF]

J Am Heart Assoc
Samuelsson AM, Bayer AL, Li J, Li Y, Lewis D, Turcotte MG, Dodge-Kafka KL, Alcaide P, Kapiloff MS.   +8 more
europepmc   +1 more source

Remote ischemic conditioning combined with transcutaneous vagus nerve stimulation reduces reperfusion injuries and improves cardiac function in acute ST-segment elevation myocardial infarctions. [PDF]

BMC Cardiovasc Disord
Wang L, Zhuang ZC, Wu YY, Yang JT, Liu LL.   +4 more
europepmc   +1 more source

Heart failure induced by cancer therapies: focus on targeted agents, mechanisms, risk prediction, and clinical management. [PDF]

Front Pharmacol
Xiao L, Lin X, Yang Z, Lin B, Xie R.
europepmc   +1 more source

An activator of phosphatidylinositol 3-kinase alpha restores cardioprotection from ischaemia/reperfusion injury in mice with coronary atherosclerosis or insulin resistance. [PDF]

Cardiovasc Res
Golforoush P, Sulaiman E, He D, Yellon DM, Davidson SM.   +4 more
europepmc   +1 more source